Patent: 5,509,905
Summary for Patent: 5,509,905
| Title: | Injector display |
| Abstract: | The invention concerns a display for a medical injection device (1) wherein an injection dose is pre-selected by rotating an operating head (2) and then is administered by axially displacing said head. Switching devices (7, 8) are apposed to the operating head (2) to actuate switches (7, 8) of which the switch positions are transmitted to a printed circuit board (13). The printed circuit board (13) preferably contains a processor, so that values such as set injection dose, the sum of administered injection doses etc. and signals concerning operational states are shown on a display system (15). |
| Inventor(s): | Michel; Peter (Burgdorf, CH) |
| Assignee: | Medimpex Ets (LI) |
| Application Number: | 08/133,125 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,509,905
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | April 20, 2000 | 5,509,905 | 2013-10-13 |
| Sanofi-aventis U.s. Llc | LANTUS | insulin glargine | Injection | 021081 | April 25, 2007 | 5,509,905 | 2013-10-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,509,905
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2108692 | ⤷ Start Trial |
| Switzerland | 682805 | ⤷ Start Trial |
| Germany | 59300890 | ⤷ Start Trial |
| European Patent Office | 0581925 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 9316743 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
